- Home
- BCRX vs ARR Comparison
BCRX vs ARR Comparison
Compare BCRX & ARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCRX | ARR |
|---|---|---|
| Founded | 1986 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | BCRX | ARR |
|---|---|---|
| Price | $9.55 | $17.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 3 |
| Target Price | ★ $20.82 | $18.50 |
| AVG Volume (30 Days) | ★ 5.5M | 3.4M |
| Earning Date | 05-06-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 16.69% |
| EPS Growth | ★ 381.40 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $25,186,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.55 | N/A |
| P/E Ratio | ★ N/A | $27.18 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.00 | $13.98 |
| 52 Week High | $10.94 | $19.31 |
Technical Indicators
Market Signals| Indicator | BCRX | ARR |
|---|---|---|
| Relative Strength Index (RSI) | 58.79 | 54.87 |
| Support Level | $8.04 | $17.04 |
| Resistance Level | $10.04 | $17.76 |
| Average True Range (ATR) | 0.49 | 0.28 |
| MACD | 0.13 | 0.05 |
| Stochastic Oscillator | 50.88 | 89.02 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.